"The main advantage of having a core of dedicated, highly skilled staff supplying consistent quality controlled pluripotent cells is that it removes a large degree of variability from the experiments undertaken by my research group. The flow of cells and information has been invaluable."
Andrew Laslett, PhD, Research Team Leader, CSIRO, Molecular and Health Technologies, Melbourne, Australia

“The ASCC StemCore in Brisbane has provided hES cells to us on an ongoing basis since May 2009.  The cells we receive have undergone QA and QC procedures. Their service is professional and all of their staff are approachable and flexible and are happy to sit down and share their knowledge and troubleshoot with us if necessary. Stem cell research in Queensland would not be able to continue without the ASCC StemCore in Brisbane.”
Professor Melissa Little and Dr. Melissa Becroft, University of Queensland

“StemCore have been invaluable as a reliable source of pluripotent stem cells in virtually any growth condition we require. As a small research lab consisting of only 2 full time stem cell biologists, culture and maintenance of human embryonic stem cell lines would require the majority of our time, leaving little spare for effective research. With StemCore’s assistance we have been able to focus our research towards publications and novel approaches to investigate human embryonic stem cell biology instead of the otherwise demanding maintenance of cultures”

Dr Andrew Prowse, Australian Institute of Bioengineering and Nanotechnology, University of Queensland

“It is a great convenience to purchase quality controlled human ESC and iPSC from the ASCC StemCore in whatever format I require for my experiments, rather than having also to culture feeder cells, handle matrigel, etc. The staff in the StemCore facility are always helpful and knowledgeable, which was great help when starting out in hES/iPSC field.”

Dr Rebecca Pelekanos, University of Queensland Centre for Clinical Research

“My laboratory interacted with ASCC HES Core (Core hESC Laboratory in ASCC Melbourne) from September-October 2005 till June 2009.  As a small team just started working with human embryonic stem (ES) cells, availability of expert knowledge on maintaining hES cells in various ways, and more importantly, constant supply of early passage hES cells that had been QCed were both essential for us to jump start. If the barrier for simple maintenance of an experimental system, with which any interesting questions have to be answered, is so high, research with such system will be handled only in a large and wealthy laboratory. Without HES Core, we probably would have given up on dealing with hES cells. Long-term maintenance of ‘quality’ hES and induced-pluripotent stem (iPS) cells is still an art. Another important aspect of HES Core activity is their constant attempts to improve technologies for maintaining, storing and QCing hES/iPS cells. These are important efforts to make, but not suitable for grant-based research operated in academia. Thus, until the day comes to be able to supply hES/iPS cells by easily generating and storing them as in the case of mouse ES cells, HSC Core service will be the major advantage that Australia has in the field of pluripotent stem cell research.”
A/Professor Naoki Nakayama (Centre for Stem Cell Research, Brown Foundation Institute of Molecular Medicine, the University of Texas Health Science Center at Houston. Previously, Senior Scientist, ASCC Melbourne)